The University of Chicago Header Logo

Connection

James Millis to Middle Aged

This is a "connection" page, showing publications James Millis has written about Middle Aged.
Connection Strength

0.343
  1. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant. 2014 Feb; 14(2):356-66.
    View in: PubMed
    Score: 0.032
  2. Liver transplantation for non-hepatocellular carcinoma malignancy: Indications, limitations, and analysis of the current literature. Liver Transpl. 2010 Aug; 16(8):930-42.
    View in: PubMed
    Score: 0.025
  3. Retained colorectal foreign bodies. Dis Colon Rectum. 2006 Aug; 49(8):1240-1; author reply; 1241.
    View in: PubMed
    Score: 0.019
  4. Omega jejunoduodenal anastomosis for pancreas transplant. J Am Coll Surg. 2006 Jun; 202(6):1021-4.
    View in: PubMed
    Score: 0.019
  5. Devastating and fatal complications associated with combined vascular and bile duct injuries during cholecystectomy. Arch Surg. 2002 Jun; 137(6):703-8; discussion 708-10.
    View in: PubMed
    Score: 0.014
  6. Is any method of vascular control superior in hepatic resection of metastatic cancers? Longmire clamping, pringle maneuver, and total vascular isolation. Arch Surg. 2001 May; 136(5):569-75.
    View in: PubMed
    Score: 0.013
  7. Efficacy of computed tomography in detecting hepatocellular cancer in adult liver transplant candidates. Transplant Proc. 2001 Feb-Mar; 33(1-2):1854-5.
    View in: PubMed
    Score: 0.013
  8. Post-Hoc Analysis of a Randomized, Double Blind, Prospective Study at the University of Chicago: Additional Standardizations of Trial Protocol are Needed to Evaluate the Effect of a CXCR1/2 Inhibitor in Islet Allotransplantation. Cell Transplant. 2021 Jan-Dec; 30:9636897211001774.
    View in: PubMed
    Score: 0.013
  9. Pancreatic beta cell/islet mass and body mass index. Islets. 2019; 11(1):1-9.
    View in: PubMed
    Score: 0.011
  10. Assessment of simple indices based on a single fasting blood sample as a tool to estimate beta-cell function after total pancreatectomy with islet autotransplantation - a prospective study. Transpl Int. 2019 03; 32(3):280-290.
    View in: PubMed
    Score: 0.011
  11. Complications in 100 living-liver donors. Ann Surg. 1998 Aug; 228(2):214-9.
    View in: PubMed
    Score: 0.011
  12. Comparative evaluation of simple indices using a single fasting blood sample to estimate beta cell function after islet transplantation. Am J Transplant. 2018 04; 18(4):990-997.
    View in: PubMed
    Score: 0.011
  13. Impact of a liberalized donor acceptance policy on liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):484.
    View in: PubMed
    Score: 0.010
  14. A Multicenter Study: North American Islet Donor Score in Donor Pancreas Selection for Human Islet Isolation for Transplantation. Cell Transplant. 2016; 25(8):1515-1523.
    View in: PubMed
    Score: 0.009
  15. Preservation of beta cell function after pancreatic islet autotransplantation: University of Chicago experience. Am Surg. 2015 Apr; 81(4):421-7.
    View in: PubMed
    Score: 0.009
  16. Malignant mixed tumor (carcinosarcoma) of the pancreas: a case report supporting organ-induced differentiation of malignancy. Surgery. 1994 Jan; 115(1):132-7.
    View in: PubMed
    Score: 0.008
  17. Regional differences in islet distribution in the human pancreas--preferential beta-cell loss in the head region in patients with type 2 diabetes. PLoS One. 2013; 8(6):e67454.
    View in: PubMed
    Score: 0.008
  18. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl. 2012 Jun; 18(6):716-26.
    View in: PubMed
    Score: 0.007
  19. Use of immune function test in monitoring immunosuppression in liver transplant recipients. Clin Transplant. 2012 Nov-Dec; 26(6):826-32.
    View in: PubMed
    Score: 0.007
  20. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010 Nov 18; 363(21):2004-14.
    View in: PubMed
    Score: 0.006
  21. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut. 2010 Dec; 59(12):1687-93.
    View in: PubMed
    Score: 0.006
  22. Entecavir therapy in a hepatitis B-related decompensated cirrhotic patient. South Med J. 2008 Nov; 101(11):1173-6.
    View in: PubMed
    Score: 0.006
  23. Uncharacteristically early fatal intraperitoneal rupture of hepatocellular carcinoma following transarterial chemoembolization. Dig Liver Dis. 2009 Feb; 41(2):175-6.
    View in: PubMed
    Score: 0.006
  24. Current state of combined heart-liver transplantation in the United States. J Heart Lung Transplant. 2008 Jul; 27(7):753-9.
    View in: PubMed
    Score: 0.005
  25. Liver transplantation at UCLA: a report of clinical activities. Clin Transpl. 1988; 29-34.
    View in: PubMed
    Score: 0.005
  26. Transjugular intrahepatic portosystemic shunt placement in liver transplant recipients: experiences with pediatric and adult patients. AJR Am J Roentgenol. 2005 Mar; 184(3):920-5.
    View in: PubMed
    Score: 0.004
  27. Epidemiology and clinical consequences of vancomycin-resistant enterococci in liver transplant patients. Transplantation. 2001 Sep 27; 72(6):1032-7.
    View in: PubMed
    Score: 0.003
  28. Open cardiotomy for removal of migrating transjugular intrahepatic portosystemic shunt stent combined with liver transplantation. Transplantation. 2001 Apr 15; 71(7):1000-3.
    View in: PubMed
    Score: 0.003
  29. Surgical management of benign tumors of the liver. Int J Gastrointest Cancer. 2001; 30(3):141-6.
    View in: PubMed
    Score: 0.003
  30. Hepatic resection: effective treatment for primary and secondary tumors. Surgery. 2000 Oct; 128(4):686-93.
    View in: PubMed
    Score: 0.003
  31. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg. 2000 May; 135(5):530-4; discussion 534-5.
    View in: PubMed
    Score: 0.003
  32. Successful combined liver-heart transplantation in adults: report of three patients and review of the literature. Transplantation. 1999 Nov 15; 68(9):1423-7.
    View in: PubMed
    Score: 0.003
  33. Rapidly progressive liver injury and fatal alcoholic hepatitis occurring after liver transplantation in alcoholic patients. Transplantation. 1999 Jun 27; 67(12):1562-8.
    View in: PubMed
    Score: 0.003
  34. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. Transplant Proc. 1998 Jun; 30(4):1234-5.
    View in: PubMed
    Score: 0.003
  35. Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases. Transplant Proc. 1998 Mar; 30(2):270-1.
    View in: PubMed
    Score: 0.003
  36. Coccidioidomycosis in liver transplant patients. Clin Infect Dis. 1997 Feb; 24(2):216-21.
    View in: PubMed
    Score: 0.002
  37. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. Transplantation. 1996 Oct 15; 62(7):906-10.
    View in: PubMed
    Score: 0.002
  38. Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation. 1996 Aug 27; 62(4):451-6.
    View in: PubMed
    Score: 0.002
  39. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32.
    View in: PubMed
    Score: 0.002
  40. Living-donor liver transplantation at UCLA. Am J Surg. 1995 May; 169(5):529-32.
    View in: PubMed
    Score: 0.002
  41. Liver transplantation for chronic hepatitis B in Asians. Transplantation. 1994 May 15; 57(9):1393-5.
    View in: PubMed
    Score: 0.002
  42. One thousand liver transplants. The lessons learned. Ann Surg. 1994 May; 219(5):490-7; discussion 498-9.
    View in: PubMed
    Score: 0.002
  43. Radical resection combined with liver transplantation for foregut tumors. Am Surg. 1993 Dec; 59(12):806-12.
    View in: PubMed
    Score: 0.002
  44. Celiac compression syndrome and liver transplantation. Ann Surg. 1993 Jul; 218(1):10-2.
    View in: PubMed
    Score: 0.002
  45. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg. 1990 Oct; 125(10):1261-6; discussion 1266-8.
    View in: PubMed
    Score: 0.002
  46. The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation. Transplantation. 1990 Aug; 50(2):219-25.
    View in: PubMed
    Score: 0.002
  47. Hepatic artery reconstruction during liver transplantation. Transplantation. 1989 Feb; 47(2):403-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.